In addition, Western blot results showed the upregulation of cleaved-caspase9 and the downregulation of BCL-2 in MCL cells in ganetespib-ibrutinib combination group, which explained changes of cell apoptosis after drug treatment at the molecular level (Figure 2O). The gene discussed is BCL2; the disease is mantle cell lymphoma.